EXCRETION PATHWAYS OF AMPHOTERICIN-B

被引:75
作者
CRAVEN, PC
LUDDEN, TM
DRUTZ, DJ
ROGERS, W
HAEGELE, KA
SKRDLANT, HB
机构
[1] VET ADM AUDIE L MURPHY MEM HOSP,DEPT MED,DIV INFECT DIS,SAN ANTONIO,TX
[2] VET ADM AUDIE L MURPHY MEM HOSP,DEPT PHARMACOL,DIV CLIN PHARMACOL,SAN ANTONIO,TX
[3] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
关键词
D O I
10.1093/infdis/140.3.329
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of the biliary system in excretion of amphotericin B was explored in a dog model that allowed either external diversion of all bile or complete biliary obstruction. In dogs with biliary diversion, which were given a single dose o£ amphotericin B intravenously, excretion of amphotericin B in the bile lasted for seven to 10 days and accounted for only 3% ± 2% (mean ± sd) of the dose, whereas excretion in the urine was prolonged (23-35 days) and greater (21% ± 5% of the dose); the stool contained no amphotericin B. However, bile salt depletion may have depressed bilary excretion of amphotericin B: In a dog with an intact biliary system, 19% of the dose was excreted in the stool over 11 days. In dogs given amphotericin B daily, serum levels were 19% ± 3% higher during periods of biliary obstruction than during periods of tree bile flow (P < 0.05). Thus, excretion of amphotericin B in the bile (≤ 19% of the dose) and in the urine (21% of the dose) accounted for a minority of total drug clearance. Nevertheless, prolonged excretion of amphotericin B by these routes after a single dose suggests that infrequent doses of amphotericin B may provide effective treatment for certain forms of fungal infection. © 1979 by The University of Chicago.
引用
收藏
页码:329 / 341
页数:13
相关论文
共 29 条
[11]  
HAMILTONMILLER JM, 1973, BACTERIOL REV, V37, P166
[12]  
Haslewood G.A., 1967, BILE SALTS
[13]   AMPHOTERICIN B TOXICITY - CHANGES IN RENAL MORPHOLOGY [J].
HILL, GJ .
ANNALS OF INTERNAL MEDICINE, 1964, 61 (02) :349-+
[14]   CHEMOTHERAPY OF SYSTEMIC FUNGAL DISEASES [J].
HOEPRICH, PD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1978, 18 :205-231
[15]   COMPARATIVE PHARMACOLOGY OF AMPHOTERICIN-B AND AMPHOTERICIN-B METHYL-ESTER IN NON-HUMAN PRIMATE, MACACA-MULATTA [J].
JAGDIS, FA ;
HOEPRICH, PD ;
LAWRENCE, RM ;
SCHAFFNER, CP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (05) :582-590
[16]  
JAGDIS FA, 1976, CLIN RES, V24, pA453
[17]  
JAGDIS JA, 1977, 16TH P INT C ANT AG
[18]   COMPARISON OF AMPHOTERICIN-B AND AMPHOTERICIN-B METHYL-ESTER - EFFICACY IN MURINE COCCIDIOIDOMYCOSIS AND TOXICITY [J].
LAWRENCE, RM ;
HOEPRICH, PD .
JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (02) :168-174
[19]  
LEVY G, 1975, HDB EXPTL PHARMACO 3, V28, P1
[20]  
LOURIA DONALD B., 1958, ANTIBIOT MED AND CLIN THER, V5, P295